US Broker Ratings

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 21% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector specializing in the development and commercialization of therapies for neurological, neuroendocrine, and neuropsychiatric disorders,..

Merck & Co. (MRK) Stock Analysis: Navigating a 27% Potential Upside in Healthcare

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, offers investors a compelling opportunity with a significant potential upside of 27.30% based on..

Exact Sciences Corporation (EXAS) Stock Analysis: Evaluating a 35.66% Upside Potential Amidst Robust Buy Ratings

Exact Sciences Corporation (NASDAQ: EXAS) stands out in the healthcare sector with its significant contributions to the diagnostics and research industry. Headquartered in Madison, Wisconsin, this..

Chemed Corp (CHE) Stock Analysis: Exploring a Robust 43.29% Potential Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, stands at a fascinating juncture for savvy investors, particularly with a potential upside of 43.29%..

Align Technology, Inc. (ALGN) Investor Outlook: Embracing a 21.79% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN) stands as a pivotal player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Tempe, Arizona,..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Analyst Ratings Highlight 28% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing investor attention in the biotechnology sector with its innovative approach to developing transformative medicines for genetic diseases and cancers...

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a 12% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based oncology powerhouse, is capturing the attention of investors with its promising pipeline and an impressive 12.36% upside potential. With a..

Lantheus Holdings (LNTH) Stock Analysis: A Potential 82.83% Upside Amid Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing the attention of..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating a 6.72% Upside in a Competitive Healthcare Market

Tenet Healthcare Corporation (NYSE: THC), a significant player in the U.S. healthcare landscape, provides a compelling investment opportunity for those eyeing the medical care facilities sector...

Avantor, Inc. (AVTR) Stock Analysis: Investor Outlook with a 27.34% Potential Upside

Avantor, Inc. (NYSE: AVTR) has emerged as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing a 25% Upside Potential Amidst Revenue Growth

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector, primarily focuses on innovative solutions within the medical devices industry. With a market capitalization of..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Valuation and Growth in a Dynamic Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the medical distribution industry based in the United States, is a key supplier of healthcare products and..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 75% Revenue Growth in the Healthcare Sector

Tempus AI, Inc. (TEM) is making waves in the healthcare technology sector, and for good reason. With a remarkable 75.40% revenue growth, the company is positioned..

Option Care Health, Inc. (OPCH): Investor Outlook with a 30.79% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in home and alternate site infusion services, is making waves in the healthcare sector. As the company continues..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating the 8.71% Dividend Yield Amidst Market Challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a significant player in the healthcare sector, operating through a diverse range of services from retail pharmacy to..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analyzing the 67% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, offers a compelling opportunity for investors with a reported potential upside of 67.22%. Specializing..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 38.62% Potential Upside Amidst Biotech Innovations

For investors with a keen eye on the biotechnology sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents an intriguing opportunity. With a market capitalization of $6.65 billion,..

Roivant Sciences Ltd. (ROIV) Stock Report: Analysts See 46% Upside as Biotech Innovator Advances Pipeline

Roivant Sciences Ltd. (NASDAQ: ROIV) has captured the attention of investors with its promising pipeline of biopharmaceutical innovations. Based in London, this healthcare juggernaut operates within..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 21.79% Upside Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a titan in the healthcare sector, with a robust market capitalization of $51.26 billion. Operating within the medical..

Qiagen N.V. (QGEN) Investor Outlook: Navigating Diagnostics Growth with a 3.66% Upside Potential

Investors eyeing opportunities in the healthcare sector might find Qiagen N.V. (NYSE: QGEN) an intriguing proposition, as the Dutch diagnostics and research company continues to leverage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds